Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Sobi ® (STO:SOBI) today announced the European Medicines Agency (EMA) has validated an indication extension application for Aspaveli ® (pegcetacoplan) ...

After the excess of the '80s, the 1990s seemed poised to return to the glory days of the 1970s. With the birth of the ...

Saskatoon-based DEEP Earth Energy Corp. is planning to produce what it terms “emissions-free baseload power” from Canada’s ...